515 related articles for article (PubMed ID: 22080977)
1. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.
Reddy PH; Shirendeb UP
Biochim Biophys Acta; 2012 Feb; 1822(2):101-10. PubMed ID: 22080977
[TBL] [Abstract][Full Text] [Related]
2. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.
Sawant N; Morton H; Kshirsagar S; Reddy AP; Reddy PH
Mol Neurobiol; 2021 Dec; 58(12):6350-6377. PubMed ID: 34519969
[TBL] [Abstract][Full Text] [Related]
4. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
[TBL] [Abstract][Full Text] [Related]
5. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation.
Wong YC; Holzbaur EL
J Neurosci; 2014 Jan; 34(4):1293-305. PubMed ID: 24453320
[TBL] [Abstract][Full Text] [Related]
6. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
[TBL] [Abstract][Full Text] [Related]
7. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
Wang H; Lim PJ; Karbowski M; Monteiro MJ
Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
[TBL] [Abstract][Full Text] [Related]
8. Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington's disease.
White JA; Krzystek TJ; Hoffmar-Glennon H; Thant C; Zimmerman K; Iacobucci G; Vail J; Thurston L; Rahman S; Gunawardena S
Acta Neuropathol Commun; 2020 Jul; 8(1):97. PubMed ID: 32611447
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
Yin X; Manczak M; Reddy PH
Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605
[TBL] [Abstract][Full Text] [Related]
10. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.
Song W; Chen J; Petrilli A; Liot G; Klinglmayr E; Zhou Y; Poquiz P; Tjong J; Pouladi MA; Hayden MR; Masliah E; Ellisman M; Rouiller I; Schwarzenbacher R; Bossy B; Perkins G; Bossy-Wetzel E
Nat Med; 2011 Mar; 17(3):377-82. PubMed ID: 21336284
[TBL] [Abstract][Full Text] [Related]
11. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.
Orr AL; Li S; Wang CE; Li H; Wang J; Rong J; Xu X; Mastroberardino PG; Greenamyre JT; Li XJ
J Neurosci; 2008 Mar; 28(11):2783-92. PubMed ID: 18337408
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria?
Sawa A
J Mol Med (Berl); 2001 Jul; 79(7):375-81. PubMed ID: 11466559
[TBL] [Abstract][Full Text] [Related]
13. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
Oliveira JM
J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
[TBL] [Abstract][Full Text] [Related]
14. Huntington's disease: a synaptopathy?
Li JY; Plomann M; Brundin P
Trends Mol Med; 2003 Oct; 9(10):414-20. PubMed ID: 14557053
[TBL] [Abstract][Full Text] [Related]
15. Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.
Han I; You Y; Kordower JH; Brady ST; Morfini GA
J Neurochem; 2010 Jun; 113(5):1073-91. PubMed ID: 20236390
[TBL] [Abstract][Full Text] [Related]
16. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
Borrell-Pagès M; Zala D; Humbert S; Saudou F
Cell Mol Life Sci; 2006 Nov; 63(22):2642-60. PubMed ID: 17041811
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial structural and functional dynamics in Huntington's disease.
Reddy PH; Mao P; Manczak M
Brain Res Rev; 2009 Jun; 61(1):33-48. PubMed ID: 19394359
[TBL] [Abstract][Full Text] [Related]
18. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
[TBL] [Abstract][Full Text] [Related]
19. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons.
Chang DT; Rintoul GL; Pandipati S; Reynolds IJ
Neurobiol Dis; 2006 May; 22(2):388-400. PubMed ID: 16473015
[TBL] [Abstract][Full Text] [Related]
20. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.
Trushina E; Dyer RB; Badger JD; Ure D; Eide L; Tran DD; Vrieze BT; Legendre-Guillemin V; McPherson PS; Mandavilli BS; Van Houten B; Zeitlin S; McNiven M; Aebersold R; Hayden M; Parisi JE; Seeberg E; Dragatsis I; Doyle K; Bender A; Chacko C; McMurray CT
Mol Cell Biol; 2004 Sep; 24(18):8195-209. PubMed ID: 15340079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
